News

A new study published on the preprint server medRxiv from King's College, London, suggests that an individual's genetic makeup may contribute to how much a person is likely to be affected by COVID-19, or whether they are likely to be infected at all.

Scientists at the HudsonAlpha Institute for Biotechnology, the University of California, San Francisco (UCSF), and the University of Alabama at Birmingham (UAB), have identified a new risk factor for multiple neurodegenerative diseases.

A new study published preprint in the non-peer-reviewed journal medRxiv in April 2020 provides a systematic review of maternal and fetal outcomes in pregnancy affected by COVID-19, as well as the risk of vertical transmission of the virus.

Pregnancy with COVID-19 is becoming more common, but the absolute number of cases is still low. This means the extent of involvement is not clear as of now. The current systematic review was aimed at covering all available reports, both published and those awaiting publication, that analyzed the effects of this infection on the mother and the baby.

Scientists set out to investigate the evolution of a gene that helps women stay pregnant: the progesterone receptor gene. The results come from an analysis of the DNA of 115 mammalian species.

People with a gene variant that puts them at high risk for Alzheimer's disease are protected from its debilitating effects if they also carry a variant of a completely different gene, investigators report in a large new study.

Scientists report that the combined effects of rare, damaging mutations present at birth have a negative impact on healthspan and longevity.